Raisio plc, stock exchange release 14 March 2025 at 8:30 EET
Raisio has closed the sale of its plant protein business and the Härkis® and Beanit® brands to the dairy and food company Valio, transferring the business to the new owner on 13 March 2025. The price of the asset deal was approximately EUR 7 million. The sale of the business is not considered to have a significant impact on EBIT in the first quarter of 2025.
The asset deal included Raisio's plant protein business, the associated fixed assets, the Härkis® and Beanit® fava bean brands, and the equipment of the factory producing plant protein products in Kauhava. The plant protein business employed 16 people, who were transferred to Valio as existing employees as part of the asset deal. Raisio has been a lessee in the Kauhava factory property and will sublease the property to Valio.
In 2024, the net sales of the plant protein business totalled EUR 4.5 million and its comparable EBIT was EUR 2.6 million in the loss. The sale of the plant protein business is expected to have a positive impact on Raisio's comparable EBIT in 2025 after the closing of the asset deal.
The deal was announced in a stock exchange release on 13 February 2025: https://www.raisio.com/en/newsroom/?article-id=E2671B99C62C1790#feed
Enquiries:
Pasi Flinkman, CEO, tel. +358 400 819 947
Mika Saarinen, CFO, tel. +358 40 072 6808
RAISIO PLC
At Raisio, we make food from the heart, with the aim of bringing health to ourselves and the Earth. We make a healthier and happier world around us by innovating and winning the hearts of our consumers. We do not work alone; instead, we rely on our cooperation networks at every stage. Our strong brands, such as Benecol® and Elovena®, turn our ambitions into reality. Through our responsibility work, we make the hard choices for consumers, so that they can choose Raisio products with confidence. We have around 350 healthy food colleagues in seven countries and export to more than 40 markets around the world. Raisio's shares are listed on Nasdaq Helsinki Ltd. In 2024, the Group's comparable net sales for continuing operations were EUR 226.8 million and the comparable EBIT was EUR 23.4 million. www.raisio.com